SkinBioTherapeutics (SBTX.LSE) Q1 2024 Earnings

22MarConfirmed
Dec 22
Q4 2022
Q3 2023
Q1 2024
-0.76
-0.51
-0.26
-0.01

Details

Expected EPS
N/A
Actual EPS
-0.7576779620665028
Surprise EPS
-0.76
Surprise Percent
+∞%

Description

SkinBioTherapeutics (SBTX.LSE) has reported earnings of -0.7576779620665028 per share for Q1 2024.

0 Comments

Share your thoughts